SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Iambic Therapeutics files for US IPO

Life sciences company Iambic Therapeutics filed for an initial public offering in the US on Monday.

Sept. 21 (Reuters) — Life sciences company Iambic Therapeutics filed for an initial public offering in the US on Monday.